Security Snapshot

Valion Bio, Inc. - Common Stock, par value $0.0001 per share (VBIO) Institutional Ownership

CUSIP: 888705308

13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

9

Shares (Excl. Options)

264,178

Price

$0.89

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
VBIO on Nasdaq
Shares outstanding
3,106,323
Price per share
$0.97
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
264,178
Total reported value
$233,432
% of total 13F portfolios
0%
Share change
+182,263
Value change
+$149,784
Number of holders
9
Price from insider filings
$0.97
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • VBIO - Valion Bio, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 888705308.
  • 9 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 7 to 9 between Q4 2025 and Q1 2026.
  • Reported value moved from $118,778 to $233,432.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 9 institutions filings for Q1 2026.

Open SEC Evidence

Security key

888705308

Latest holder period

Q1 2026

13F holders

9

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
VBIO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
3i, LP 9.9% 0% $310,601 +$31,652 307,526 +11% 3i, LP 31 Mar 2026

As of 31 Mar 2026, 9 institutional investors reported holding 264,178 shares of Valion Bio, Inc. - Common Stock, par value $0.0001 per share (VBIO). This represents 8.5% of the company’s total 3,106,323 outstanding shares.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
5
Latest
Q1 2026
Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 264,178 $233,432 +$149,784 $0.89 9
2025 Q4 81,915 $118,778 -$96,033 $1.45 7
2025 Q3 196,221 $567,079 +$437,141 $2.89 7
2025 Q2 44,961 $186,587 +$23,476 $4.14 4
2025 Q1 21 $54 +$54 $2.58 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .